06.11.2008 21:05:00

Dolby Laboratories Reports FY 2008 Fourth Quarter and Year-End Results

Dolby Laboratories, Inc. (NYSE:DLB) today announced the Company's financial results for the fourth quarter and fiscal year ended September 26, 2008.

For the fourth quarter, Dolby reported total revenue of $163.1 million, compared to $129.0 million for the fourth quarter of fiscal 2007, an increase of 26 percent. Fourth quarter net income was $48.6 million, or $0.42 per diluted share, compared to $44.2 million, or $0.39 per diluted share, for the fourth quarter of fiscal 2007.

For fiscal year 2008, Dolby reported total revenue of $640.2 million, compared to $482.0 million for fiscal year 2007, an increase of 33 percent. Net income for fiscal year 2008 was $199.5 million, or $1.74 per diluted share, compared to $142.8 million, or $1.26 per diluted share, for fiscal year 2007.

Net income for the fourth quarter and fiscal year 2008 reflects stock-based compensation expense of $5.5 million and $22.7 million, respectively, compared to $5.1 million and $19.8 million for the same periods in fiscal 2007.

Net income for the fourth quarter and fiscal year 2008 also reflects charges related to the amortization of intangibles of $3.1 million and $12.5 million, respectively, compared to $1.3 million and $3.3 million for the same periods in fiscal 2007.

"Fiscal 2008 was a strong year for us, as we continued to benefit from the adoption of Dolby technologies globally," said Bill Jasper, President and Chief Executive Officer of Dolby Laboratories. "We finished fiscal 2008 with excellent profitability, a strong balance sheet, a global brand, and a continued focus on driving the adoption of existing and new technologies across our markets.

Guidance

Dolby expects fiscal 2009 revenue to be $660 million to $720 million. Net income is expected to be $184 million to $208 million. Earnings per diluted share are expected to be $1.57 to $1.77. Included in Dolbys fiscal 2009 earnings guidance is approximately $5.0 million in estimated restructuring charges for the consolidation of manufacturing operations. The impact of this restructuring charge on net income is approximately $3.0 million, or $0.03 per diluted share. While under FAS 123R, stock-based compensation expense may vary based on factors such as stock price or volatility, Dolby expects stock-based compensation expense for the full year to be approximately $25 million. In addition, Dolby expects charges related to the amortization of intangibles for fiscal 2009 to be approximately $13 million.

The Company's Conference Call Information

Members of Dolby management will lead a conference call open to all interested parties to discuss Dolby Laboratories Q4 and fiscal 2008 year-end financial results at 2:00 p.m. PT/5:00 p.m. ET, Thursday, November 6, 2008.

Access to the teleconference will be available over the Internet from http://investor.dolby.com/medialist.cfm or by dialing 888-205-6875. International callers can access the conference call at 913-981-5582.

A replay of the call will be available beginning at 5:00 p.m. PT on November 6, 2008 until 9:00 p.m. PT on November 13, 2008 at 888-203-1112 (international callers can access the replay at 719-457-0820) using confirmation code 1214655. An archived version of the teleconference will also be available on www.dolby.com.

Forward-Looking Statements

Certain statements in this press release, including statements relating to Dolby's expectations regarding revenue, net income, earnings per diluted share, stock-based compensation expense and charges relating to the amortization of intangibles, for the fiscal year ending September 25, 2009, and the expected future benefits from our global brand and driving adoption of our existing and new technologies, are "forward-looking statements that are subject to risks and uncertainties. These forward-looking statements are based on managements current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those projected. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: risks associated with trends in the markets in which Dolby operates, including trends related to DVD and Blu-ray Disc, broadcast, personal computer, gaming, mobile, or portable device markets, and trends relating to the development of additional and newer markets for Dolby technologies; general economic risks both domestically and internationally; the timing of Dolby's receipt of royalty reports and/or payments from its licensees; Dolbys accuracy of calculation of royalties due to its licensors; Dolbys ability to develop, maintain, and strengthen relationships with industry participants; Dolbys ability to develop and deliver innovative technologies in response to new and growing markets in the entertainment industry; competitive risks; risks associated with conducting business in China and other countries, including countries that have historically limited recognition and enforcement of intellectual property and contractual rights; risks associated with the motion picture industry generally; the development and growth of the market for digital cinema and digital 3D and Dolbys ability to successfully penetrate this market; Dolbys ability to expand its business generally, and to expand its business beyond sound technologies to other technologies related to digital entertainment delivery, including acquiring and successfully integrating businesses or technologies; and other risks detailed in Dolbys Securities and Exchange Commission filings and reports, including the risks identified under the section captioned "Risk Factors in its most recent Quarterly Report on Form 10-Q. Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

About Dolby Laboratories

Dolby Laboratories (NYSE:DLB) is the global leader in technologies that are essential elements in the best entertainment experiences. Founded in 1965 and best known for high-quality audio and surround sound, Dolby® innovations enrich entertainment at the movies, at home, or on the go. Visit www.dolby.com for more information.

Dolby and the double-D symbol are registered trademarks of Dolby Laboratories. All other trademarks remain the property of their respective owners. S08/20618 DLB-F

DOLBY LABORATORIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
       
 
Fiscal Quarter Ended Fiscal Year-to-Date Ended

September 28,
2007

 

September 26,
2008

September 28,
2007

September 26,
2008

(unaudited)
(in thousands, except per share amounts)
Revenue:
Licensing $ 103,305 $ 137,756 $ 387,117 $ 537,363
Product sales 19,617 18,586 67,487 72,284
Services   6,041     6,788     27,424     30,584  
Total revenue   128,963     163,130     482,028     640,231  
 
Cost of revenue:
Cost of licensing 2,151 3,623 28,438 15,802
Cost of product sales (1) 9,978 9,806 34,497 39,455
Cost of services (1)   2,860     3,120     11,330     12,520  
Total cost of revenue   14,989     16,549     74,265     67,777  
Gross margin   113,974     146,581     407,763     572,454  
Operating expenses:
Selling, general and administrative (1) 50,536 62,815 178,802 224,090
Research and development (1) 12,459 17,082 44,109 62,080
Gain on settlements   (250 )   -     (2,100 )   (499 )
Total operating expenses   62,745     79,897     220,811     285,671  
Operating income 51,229 66,684 186,952 286,783
Other income, net   5,346     4,750     22,464     15,019  
Income before provision for income taxes and controlling interest 56,575 71,434 209,416 301,802
Provision for income taxes   (12,064 )   (22,254 )   (65,131 )   (100,770 )
Income before controlling interest 44,511 49,180 144,285 201,032
Controlling interest in net income, net of tax   (353 )   (621 )   (1,454 )   (1,574 )
Net income $ 44,158   $ 48,559   $ 142,831   $ 199,458  
 
 
Basic earnings per share $ 0.40 $ 0.43 $ 1.31 $ 1.79
Diluted earnings per share $ 0.39 $ 0.42 $ 1.26 $ 1.74
 
Weighted-average shares outstanding (basic) 110,112 112,342 109,202 111,492
Weighted-average shares outstanding (diluted) 114,118 115,010 113,573 114,781
 
 
(1) Stock-based compensation included above was classified as follows:
Cost of product sales $ 232 $ 183 $ 911 $ 853
Cost of services 41 51 148 177
Selling, general and administrative 3,875 4,110 15,334 17,267
Research and development 936 1,136 3,448 4,413
 

DOLBY LABORATORIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
   
September 28, 2007 September 26, 2008
(unaudited)
(in thousands)
ASSETS
Current assets:
Cash and cash equivalents $ 368,467 $ 394,761
Short-term investments 231,217 119,667
Accounts receivable, net 28,165 27,650
Inventories 14,883 18,133
Deferred taxes 73,686 91,824
Prepaid expenses and other current assets   17,000   39,834
Total current assets 733,418 691,869
 
Property, plant and equipment, net 85,552 87,915
Intangible assets, net 35,389 83,060
Goodwill 39,364 250,356
Long-term investments 73,224 180,996
Deferred taxes 12,393 24,900
Other assets   12,357   17,050
Total assets $ 991,697 $ 1,336,146
 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued liabilities $ 119,068 $ 156,925
Income taxes payable 9,051 4,811
Current portion of long-term debt 1,563 1,593
Deferred revenue   13,522   37,344
Total current liabilities 143,204 200,673
 
Long-term debt 9,691 7,782
Long-term deferred revenue 5,073 6,171
Deferred taxes - 16,755
Other non-current liabilities   14,294   33,414
Total liabilities 172,262 264,795
 
Controlling interest 22,279 22,098
Stockholders' equity:
Class A common stock 49 52
Class B common stock 61 60
Additional paid-in capital 375,830 434,907
Retained earnings 409,749 609,495
Accumulated other comprehensive income   11,467   4,739
Total stockholders' equity   797,156   1,049,253
Total liabilities and stockholders' equity $ 991,697 $ 1,336,146

Analysen zu Dolby Laboratories Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Dolby Laboratories Inc. 74,00 0,68% Dolby Laboratories Inc.